SCHEMBL284981

SCHEMBL284981

NCCCC(=O)CC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.62
THRB P10828 2/20 0.62
BLM P54132 2/20 0.62
KMT2A Q03164 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
GABRR1 P24046 2/20 0.62
CYP1A2 P05177 2/20 0.62
TSHR P16473 2/20 0.62
GABRR3 A8MPY1 1/20 0.62
GABRP O00591 1/20 0.62
GABRD O14764 1/20 0.62
HDAC3 O15379 1/20 0.62
GABBR2 O75899 1/20 0.62
GABRA1 P14867 1/20 0.62
GABRB1 P18505 1/20 0.62
GABRG2 P18507 1/20 0.62
GABRB3 P28472 1/20 0.62
GABRR2 P28476 1/20 0.62
SLC6A1 P30531 1/20 0.62
GABRA5 P31644 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27636882 0.97 LMNA (0.59) LMNATHRBBLMKMT2ANPSR1
SCHEMBL284865 0.92 NFKB1 (0.64) LMNATHRBBLMKMT2ANPSR1
SCHEMBL18342688 0.90 LMNA (0.65) LMNATHRBBLMKMT2ANPSR1
SCHEMBL11276320 0.83
SCHEMBL9418710 0.83 SLC22A6 (0.53) LMNATHRBBLMKMT2ANPSR1
SCHEMBL9185822 0.83 LMNA (0.53) LMNAKMT2ATSHRNFKB1CYP2D6
SCHEMBL7085714 0.81 LMNA (0.50) LMNATHRBBLMKMT2ANPSR1
SCHEMBL15566265 0.81 LMNA (0.42) LMNATHRBBLMKMT2ANPSR1
SCHEMBL11438692 0.80 TSHR (0.56) LMNATHRBKMT2ATSHRHDAC11
SCHEMBL8751902 0.80 TSHR (0.56) LMNATHRBKMT2ATSHRHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885400-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS Celexion, LLC (US) 2015-06-24 EP claimed
WO-2014028026-A9 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC (US) 2015-03-26 WO claimed
WO-2014028026-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC (US) 2014-02-20 WO claimed
US-20130017593-A1 Biological Synthesis of Difunctional Hexanes and Pentanes from Carbohydrate Feedstocks CELEXION, LLC (US) 2013-01-17 US claimed
US-12577591-B2 Microorganisms and methods for increasing co-factors GENOMATICA, INC. (US) 2026-03-17 US disclosed
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 US disclosed
US-12503711-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2025-12-23 US disclosed
CN-114728871-B Microorganisms and methods for reducing byproducts 基因组股份公司 2024-12-27 CN disclosed
US-20240182935-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2024-06-06 US disclosed
US-20240141397-A1 MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS AGAIN BIO APS (DK) 2024-05-02 US disclosed
US-11834690-B2 Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid GENOMATICA, INC. (US) 2023-12-05 US disclosed
EP-4273255-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF HEXAMETHYLENEDIAMINE Genomatica, Inc. (US) 2023-11-08 EP disclosed
WO-2012177721-A1 MICROORGANISMS FOR PRODUCING 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2012-12-27 WO disclosed
US-20120301950-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC 2012-11-29 US disclosed
US-20120301950-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC 2012-11-29 US disclosed
US-20120301950-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC 2012-11-29 US disclosed
US-20120282661-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2012-11-08 US disclosed
EP-2427544-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID Genomatica, Inc. (US) 2012-03-14 EP disclosed
US-20100317069-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID AGAIN BIO APS (DK) 2010-12-16 US disclosed
WO-2010129936-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES DDC, DAO, ODC1 LMNA 2536/4885THRB 311/4885BLM 1972/4885
US-12577591-B2 Microorganisms and methods for increasing co-factors ABAT, HADHB, MMAB LMNA 1752/4885THRB 587/4885BLM 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.